The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study.
Click here for original story, Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds
Source: ScienceDaily